EUVIMEDEUVIMED entdecken
Crossref

73228 Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials

Linda Stein Gold, April W. Armstrong, Jennifer Soung, Ronald B. Vender, Álvaro González Cantero, Matthias Hoffmann, Ofelia Reyes-Servin, Bassey Effiom Edem, Kellen Cresswell, Ya-Wen Yang, Robert Bissonnette

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB170

DOI: 10.1016/j.jaad.2026.04.698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Linda Stein Gold und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gold, L. S., Armstrong, A. W., Soung, J., Vender, R. B., Cantero, Á. G., Hoffmann, M., Reyes-Servin, O., Edem, B. E., Cresswell, K., Yang, Y., & Bissonnette, R. (2026). 73228 Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. Journal of the American Academy of Dermatology, 95(1), AB170. https://doi.org/10.1016/j.jaad.2026.04.698

Vancouver

Gold LS, Armstrong AW, Soung J, Vender RB, Cantero ÁG, Hoffmann M, et al. 73228 Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. Journal of the American Academy of Dermatology. 2026;95(1):AB170. doi:10.1016/j.jaad.2026.04.698

BibTeX
@article{Gold2026,
  author = {Gold, Linda Stein and Armstrong, April W. and Soung, Jennifer and Vender, Ronald B. and Cantero, Álvaro González and Hoffmann, Matthias and Reyes-Servin, Ofelia and Edem, Bassey Effiom and Cresswell, Kellen and Yang, Ya-Wen and Bissonnette, Robert},
  title = {73228 Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB170},
  doi = {10.1016/j.jaad.2026.04.698}
}
Kostenlos starten →